XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2023
shares
Stephen C McCluski  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Stephen C. McCluski, Chairman of the Board of Directors

On June 14, 2023, Mr. Stephen C. McCluski, the Chairman of our Board of Directors, entered into a Rule 10b5-1 trading plan that provides that he, acting through a broker, may sell up to an aggregate of 20,000 shares of our common stock, subject to adjustments for stock splits, stock combinations, stock dividends and other similar changes to our common stock. Sales of shares under the plan may begin no earlier than September 13, 2023. The plan is scheduled to terminate on November 11, 2024, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. McCluski or the broker, or as otherwise provided in the plan.
Name Mr. Stephen C. McCluski
Title Chairman of our Board of Directors
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 14, 2023
Aggregate Available 20,000
Mark A Goldberg  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Mark A. Goldberg, M.D., Director

On June 9, 2023, Dr. Mark A. Goldberg, a member of our Board of Directors, entered into a Rule 10b5-1 trading plan that provides that he, acting through a broker, may sell up to an aggregate of 10,000 shares of our common stock, subject to adjustments for stock splits, stock combinations, stock dividends and other similar changes to our common stock. Sales of shares under the plan may begin no earlier than October 30, 2023. The plan is scheduled to terminate on November 10, 2023, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Dr. Goldberg or the broker, or as otherwise provided in the plan.
Name Dr. Mark A. Goldberg
Title Board of Directors
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 9, 2023
Aggregate Available 10,000
Kristine Peterson  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Kristine Peterson, Director

On June 11, 2023, Ms. Kristine Peterson, a member of our Board of Directors, entered into a Rule 10b5-1 trading plan that provides that she, acting through a broker, may sell up to an aggregate of 30,000 shares of our common stock, subject to adjustments for stock splits, stock combinations, stock dividends and other similar changes to our common stock. Sales of shares under the plan may begin no earlier than September 12, 2023. The plan is scheduled to terminate on December 29, 2023, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Ms. Peterson or the broker, or as otherwise provided in the plan.

Name Ms. Kristine Peterson
Title Board of Directors
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 11, 2023
Aggregate Available 30,000
Mark J Enyedy  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Mark J. Enyedy, President and Chief Executive Officer, and Director

On June 13, 2023, Mr. Mark J. Enyedy, our President and Chief Executive Officer and a member of our Board of Directors, entered into a Rule 10b5-1 trading plan that provides that he, acting through a broker, may sell the number of shares of our common stock as is necessary to raise funds sufficient to cover withholding taxes in connection with the vesting of restricted stock units. Sales of shares under the plan may begin no earlier than February 5, 2024. The plan is scheduled to terminate on February 27, 2026, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Enyedy or the broker, or as otherwise provided in the plan.

Name Mr. Mark J. Enyedy
Title President and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 13, 2023
Stacy A Coen  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Stacy A. Coen, Senior Vice President, Chief Business Officer

On June 15, 2023, Ms. Stacy A. Coen, our Senior Vice President, Chief Business Officer, entered into a Rule 10b5-1 trading plan that provides that she, acting through a broker, may sell the number of shares of our common stock as is necessary to raise funds sufficient to cover withholding taxes in connection with the vesting of restricted stock units. Sales of shares under the plan may begin no earlier than February 5, 2024. The plan is scheduled to terminate on February 27, 2026, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Ms. Coen or the broker, or as otherwise provided in the plan.

Name Ms. Stacy A. Coen
Title Senior Vice President, Chief Business Officer
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 15, 2023
Renee Lentini  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Renee Lentini, Vice President, Finance, Chief Accounting Officer, and Interim Chief Financial Officer

On June 6, 2023, Ms. Renee Lentini, our Vice President, Finance, Chief Accounting Officer, and Interim Chief Financial Officer, entered into a Rule 10b5-1 trading plan that provides that she, acting through a broker, may sell the number of shares of our common stock as is necessary to raise funds sufficient to cover withholding taxes in connection with the vesting of restricted stock units. Sales of shares under the plan may begin no earlier than December 26, 2023. The plan is scheduled to terminate on February 27, 2026, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Ms. Lentini or the broker, or as otherwise provided in the plan.

Name Ms. Renee Lentini
Title Vice President, Finance, Chief Accounting Officer, and Interim Chief Financial Officer
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 6, 2023
Rule10b5-1 Trading Plan | Anna Berkenblit  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Anna Berkenblit, M.D., Senior Vice President, Chief Medical Officer

On June 8, 2023, Dr. Anna Berkenblit, our Senior Vice President, Chief Medical Officer, entered into a Rule 10b5-1 trading plan that provides that she, acting through a broker, may sell the number of shares of our common stock as is necessary to raise funds sufficient to cover withholding taxes in connection with the vesting of restricted stock units. Sales of shares under the plan may begin no earlier than February 5, 2024. The plan is scheduled to terminate on February 27, 2026, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Dr. Berkenblit or the broker, or as otherwise provided in the plan.

Name Dr. Anna Berkenblit
Title Senior Vice President, Chief Medical Officer
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 8, 2023
Rule10b5-1 Trading Plan | Theresa G Wingrove  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Theresa G. Wingrove, Ph.D., Senior Vice President, Regulatory Affairs and Quality

On June 13, 2023, Dr. Theresa G. Wingrove, our Senior Vice President, Regulatory Affairs and Quality, entered into a Rule 10b5-1 trading plan that provides that she, acting through a broker, may sell the number of shares of our common stock as is necessary to raise funds sufficient to cover withholding taxes in connection with the vesting of restricted stock units. Sales of shares under the plan may begin no earlier than February 5, 2024.The plan is scheduled to terminate on February 27, 2026, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Dr. Wingrove or the broker, or as otherwise provided in the plan.

Name Dr. Theresa G. Wingrove
Title Senior Vice President, Regulatory Affairs and Quality
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 13, 2023
Separate Rule10b5-1 Trading Plan | Anna Berkenblit  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Also on June 8, 2023, Dr. Berkenblit entered into a separate Rule 10b5-1 trading plan that provides that she, acting through a broker, may sell up to an aggregate of 1,172,876 shares of our common stock, subject to adjustments for stock splits, stock combinations, stock dividends and other similar changes to our common stock, inclusive of the number of shares of our common stock as is necessary to raise funds sufficient to cover withholding taxes and the exercise price, in connection with the exercise of stock options. Sales of shares under the plan may begin no earlier than September 7, 2023. The plan is scheduled to terminate on February 28, 2024, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Dr. Berkenblit or the broker, or as otherwise provided in the plan.

Name Dr. Anna Berkenblit
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 8, 2023
Aggregate Available 1,172,876
Separate Rule10b5-1 Trading Plan | Theresa G Wingrove  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Also on June 13, 2023, Dr. Wingrove entered into a Rule 10b5-1 trading plan that provides that she, acting through a broker, may sell up to an aggregate of 1,185,296 shares of our common stock, subject to adjustments for stock splits, stock combinations, stock dividends and other similar changes to our common stock, inclusive of the number of shares of our common stock as is necessary to raise funds sufficient to cover withholding taxes and the exercise price, in connection with the exercise of stock options. Sales of shares under the plan may begin no earlier than September 15, 2023. The plan is scheduled to terminate on April 30, 2024, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Dr. Wingrove or the broker, or as otherwise provided in the plan.

Name Dr. Theresa G. Wingrove
Rule 10b5-1 Arrangement Adopted false
Adoption Date June 13, 2023
Aggregate Available 1,185,296